Study Links Mono Age and Sex to MS Risk
A large Ontario population study identifies female sex, infection at ages 10 to 25, and mental health care use as factors tied to higher multiple sclerosis rates after infectious mononucleosis.
Updated on Nov. 19, 2026 in Diseases — General

A large Ontario population study of 671,410 infectious mononucleosis cases found that 2,470 people, or 0.4%, later developed multiple sclerosis over a median follow-up of 16.7 years. The findings point to female sex, infection between ages 10 and 25, and mental health care use as factors associated with higher rates.
Why it matters
The results may help clinicians identify high-risk individuals for secondary prevention after mononucleosis. The authors note the findings may not generalize to asymptomatic or mild Epstein-Barr virus infection.
The cohort of 671,410 cases showed a median time of 11.4 years from mononucleosis to multiple sclerosis. Hazard ratios were 1.9 for female sex, 6.0 for infection at ages 10 to 25, 1.2 for mental health care use, and 0.5 for immigrant status.
The details
Researchers identified infectious mononucleosis cases from 1992 to 2017 using International Classification of Diseases codes, and tracked multiple sclerosis cases through 2022 with a validated algorithm. The study drew on health claims data from Ontario, Canada.
Timeline
Infectious mononucleosis cases were identified between April 1, 1992, and March 31, 2017.
Multiple sclerosis cases were identified between May 1, 1992, and March 31, 2022.
Health Landscape
The study follows earlier research linking Epstein-Barr virus infection to later multiple sclerosis risk, and it adds population-scale claims data from Ontario to identify which subgroups show the highest hazard. It shifts attention from infection alone toward risk stratification based on age at infection, sex, and mental health care use.
People with a history of infectious mononucleosis, particularly those infected between ages 10 and 25, may benefit from awareness of this association. The study does not yet establish changes to screening, treatment, or routine care for these groups.
The takeaway
Anyone with a history of mononucleosis in adolescence or early adulthood should keep this association in mind when discussing long-term neurological health with a clinician. Early awareness supports informed conversations rather than prompting changes to care on its own.
Further reading
Explore more on Diseases — General to see how infections like mononucleosis are studied for long-term health outcomes.
Source note: This article includes information reported by European Medical Journal.






